Southern Research Institute

University of North Carolina at Chapel Hill

Vanderbilt University

Syed Kaleem Ahmed

Corinne E Augelli-Szafran

Ashish Kumar Pathak

Mark J Suto

Joseph A Maddry

Ralph Baric

Omar Moukha-Chafiq

Timothy Patrick Sheahan

Mark R Denison

Amy Catherine Sims

Shilpa Dutta

John Phillip Tillotson

The present disclosure is concerned with substituted phenyl ethynyl pyridine carboxamide compounds, pharmaceutical compositions comprising the compounds, and methods of treating viral infections due to a Coronavirus such as, for example, Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus disease 2019 (SARS-CoV-2), using the compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus

The present disclosure is concerned with benzoannulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Benzoannulene derivatives as antiviral agents

The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Benzo annulenes as antiviral agents

Growing community of inventors

Hoover, AL, United States of America

Syed Kaleem Ahmed